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Abstract
Background: Negative symptoms (NS) may be observed in the general population in an attenuated form and in
high-risk mental states. However, they have been less studied in the general population than positive symptoms, in
spite of their importance at the insidious onset of schizophrenia and their appearance before positive symptoms.
This study aimed to analyze the empirical structure of the Spanish version of the Self-Evaluation of Negative
Symptoms (SNS) Scale and find its psychometric properties and invariance of measurement across sex and age in a
sample of adolescents.
Methods: The sample consisted of 4521 adolescents (53.6% female) from 11 to 18 years of age.
Results: Confirmatory Factor Analysis of the SNS confirmed an internal structure of five first-order factors by the
characteristic dimensions of NS: avolition, social withdrawal, diminished emotional range, anhedonia, alogia, and
one second-order factor which includes the total NS score. Multi-group confirmatory factor analysis showed that
the scale was invariant across sex and age. Total scale reliability was adequate. A strong relationship was found
between the SNS with depressive symptomatology, moderate with ideas of reference and low with aberrant
salience. Conclusion: The results back use of the Spanish version of the SNS scale for detection of NS in the general
population of adolescents.
Keywords: Negative symptoms, Adolescence, SNS, Psychosis, General population
Background
Negative symptoms (NS) are defined as the diminution in
or absence of affective-motivational responses typical of
adapted functioning [1]. It is generally agreed that NS may
be summarized as a diminution or loss of: range/intensity
of affective responses (blunted affect), spontaneous speech
(alogia), social interest (social withdrawal), interest/main-
tenance of activities (avolition), enjoyment in carrying out
activities (anhedonia) [2–5], and more recently, loss of nor-
mal distress has been added [6]. Factor analyses of the NS
scales show two differentiated factors: diminished expres-
sion (expressive), and avolition/apathy/amotivation (experi-
ential) [7–9].
NS are salient in the insidious onset of schizophrenia,
and are major in one third to half of first episodes [10],
appearing before positive symptoms [11], and predicting
them [12]. Although NS are observed in at least 50% of
persons with schizophrenia [3] and 70% before a psychotic
episode [13], they are not exclusive to it, but are also im-
portant in affective and cognitive disorders [14]. In the
schizophrenia spectrum, they are more frequent, long-
lasting, and avolition/apathy/amotivation is more promin-
ent than the expressive component. Outside of this
spectrum, they tend to be transitory and secondary [15].
As NS tend to precede positive symptoms and the on-
set of psychotic decompensation, it would have to be
wondered whether it is possible to observe NS in the
general population in order to improve early identifica-
tion of psychosis. This would imply that NS represent
Psychotic-Like Experiences (PLE), in the sense that is
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usually applied to subthreshold positive symptoms, and
would then be considered on a continuum from healthy
functioning to frank syndromes [16].
Although the nearly complete absence of NS in the
general population has often been mentioned, in ana-
lyses of large populations, somewhat over 20% of the
participants have been observed to show at least one NS
[17]. There is therefore evidence that NS are expressed,
at least in an attenuated form, in the general population
like PLEs [18–20].
However, it has been said that while positive indicators
fit well to a dimensional perspective, NS may be repre-
sented better from a categorical perspective [21]. In gen-
eral, a quasi-continuum relationship between the general
population and psychosis is alluded to when positive and
negative symptoms and other indicators characteristic of
the onset of psychosis are approached [22, 23].
Since the first psychotic episode usually occurs between
15 and 30 years of age, adolescence is a critical period for
study of NS [24]. Adolescent PLEs show a variety of pat-
terns: paranoid thoughts and/or hallucinations, and iso-
lated NS, in addition to anxiety and depression as risk
factors. Observed experiences corroborated in the general
population include diminished range of expression and
anhedonia dimensions, for which a large proportion of ad-
olescents do not request clinical help [25].
As PLEs are weak positive predictors of the transition
to psychosis, subthreshold NS may be better predictors
of its onset [26], and their study in an adolescent popu-
lation could be important, even among those who have
not yet requested clinical help [27]. Calkins et al. [28]
verified the persistence or worsening of 51% of the base-
line indicators at a two-year follow-up of community
youths, for which positive indicators had a predictive
value of 0.51 and negative of 0.83. These authors empha-
sized that youths with persistent symptomatology do not
always seek help, which is relevant for early detection of
psychosis and its prognosis.
Therefore, transfer of the study of NS to the adoles-
cent evolutionary period is of interest. Considering the
combination of positive and negative indicators, their
persistence and severity, their study in the general popu-
lation is important to progress in the study of PLE or at-
tenuated psychotic symptoms [29].
Attention has been given NS in studies of youths with
at-risk mental states, due to the low predictive power of
traditional UHR (Ultra High Risk) criteria for psychosis.
Moderate to severe NS are often found in adolescents
at clinical risk [30, 31], where persistence is the best
predictor of transition to psychosis, ahead of severity
[32, 33], and presence of positive [34] and disorganized
[35] symptoms.
Of the NS which best predict the transition to psych-
osis with UHR criteria, the best are blunted affect [36],
and anhedonia [37–40], indicators which are maintained
in those who do not transition [41].
However, it is not sufficiently clear whether NS with
UHR criteria are predictors only of developing psychosis,
or also of other severe psychopathologies such as emo-
tional disorders [42]. For example, the importance of
mood alteration has been emphasized in clinical trajec-
tories of UHR [43]. It has also been suggested that some
NS, such as avolition, may have to do with anxiety be-
cause of the first psychotic symptoms, as a way of pro-
tecting self-esteem [44], which would explain symptoms
of anxiety and depression among those who do not tran-
sition to psychosis.
Some recent results specify, however, that anhedonia
in UHR participants who transitioned to psychosis, is in-
dependent of concurrent positive and depressive symp-
toms (including suicidal ideation) [45]. This emphasizes
anhedonia as an early risk characteristic for psychosis,
and more related to severity of NS than to depression.
In view of all of the above, the analysis and follow-up
of NS as early prodromal symptoms in adolescence is
relevant. The NS become more frequent and their sever-
ity fluctuates when the psychotic episode has developed
than in the UHR state itself [39, 44], increasing the risk
of psychosis and worsening the prognosis in UHR [46].
Whether like PLE (transitory) or defined prodromal indi-
cators (clearly stable), it is advisable to have evaluation in-
struments which can identify NS in adolescence; an initial
screening that facilitates characterization of these manifes-
tations, and presumably, sheds light on the processes prior
to onset of psychosis. However, there are not many self-
report instruments evaluating the different dimensions of
NS. A review by Lincoln, Dollfus and Lyne [47] highlighted
12 scales evaluating NS, but only three are exclusively for
NS. Of the other nine, six evaluate subdomains of NS and
three are psychopathological scales with some NS. Of these
12 scales, four are adapted to Spanish, but none of them is
specific to evaluation of NS.
The SNS scale [11] is to date the most complete,
as well as the briefest, self-report for evaluating the
dimensions of NS: social withdrawal, avolition, alo-
gia, anhedonia and diminished emotional range. It
has been translated into sixteen languages and has
demonstrated adequate psychometric properties of
reliability, evidence of convergent, discriminant and
construct validity [47].
The general objective of this study was to adapt and
validate a Spanish version of the SNS as an NS instru-
ment for application to the general adolescent popula-
tion. Early identification of NS could be of enormous
utility for a symptomatology which may become persist-
ent and erode functioning [11]. The self-report may be
more useful and easier to apply in a community popula-
tion which has not requested medical help. This format
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can communicate experiential aspects hard for an ado-
lescent to transmit spontaneously, showing as it has with
patients with schizophrenia, the validity and reliability of
self-reported responses on the symptoms [48].
The specific objectives of this study enabled several
precise analyses of NS in adolescents in the general
population. These objectives were to: 1) Analyze partici-
pants’ responses to each item of the SNS scale and its
psychometric characteristics, 2) Study the factor struc-
ture of the SNS scale, comparing its structure to the one
found in other studies for adult and patient populations,
3) Analyze the scale’s invariance of measurement across
sex and age, 4) Study the psychometric properties of the
SNS scale, its reliability and convergent and divergent
validity, for use in the general population, and 5) Find
the cutoff point of the SNS scale, its sensitivity and spe-
cificity in adolescents.
Method
Participants
The final sample consisted of 4521 participants (53.6%
female) in Western Andalusia (Spain) after exclusion of
137 participants because they were over the age of 18 or
had not filled out the tests properly. The average age
was 14.32 (SD = 1.66, range 11–18 years). The average
Hollingshead [49] Social Class Index (SCI) was 44.83
(mean social class, SD = 21.48).
Measures
First self-reported evaluation (instrument developed by
authors)
This identified the social class index (SCI) [45], current
illnesses, psychopathological antecedents, history and
duration of symptoms, psychopharmacological treat-
ments and use of other drugs.
Self-evaluation of negative symptoms [11]
The scale is comprised of 20 items with three answer
choices (0 = “strongly disagree”, 1 = “somewhat agree”,
2 = “strongly agree”). A total score can be found by add-
ing up the answers to all the items. The scale covers five
dimensions: avolition, social withdrawal, diminished
emotional range, anhedonia, and alogia. Avolition evalu-
ates the lack of motivation, initiative and energy for car-
rying out different activities as well as maintaining a
regular habit. Example item, 15. There are many things I
don’t do because of lack of motivation or because I don’t
feel like it. Social withdrawal refers to the preference for
being alone and low need for social contact. Example
item 4. I don’t particularly try to contact and meet
friends (letters, telephone, text messaging, etc.). Dimin-
ished emotional range refers to difficulty in experiencing
positive and/or negative emotions. Example item, 6.
There are many happy or sad things in life but I don’t
feel concerned by them. The items assessing anhedonia
refer to reduced ability to experience pleasure. Example
item, 19. When I imagine doing one thing or another, I
don’t feel any particular pleasure in the idea. Alogia as-
sesses the difficulty for communicating and interacting
with others. Example item, 10. I find it 10 times harder
to talk than most people do.
A factor analysis by the authors of the scale found two
factors with patients with schizophrenia and schizoaffective
disorder. The first factor contained avolition, asociality, alo-
gia and anhedonia, and the second factor, diminished emo-
tional range. The Cronbach’s alpha found by the authors
was .86.
The aberrant salience inventory [50]
Spanish version by Fernández-León et al. [51]. This 29-
item true-or-false scale is a measure of proneness to
psychosis which evaluates assignment of meaning or im-
portance to neutral or irrelevant stimuli. The authors
found a Cronbach’s alpha = .89 and adequate convergent
and discriminant validity. The Spanish version of the
ASI has an α of up to .83.
Referential thinking scale (REF) [52]
This is a 34-item true-or-false self-report questionnaire
on ideas of reference. High scores show overinterpreta-
tion of environmental signs and attribution of a special
meaning for the subject. The scale has an internal
consistency of .83 to .85, retest reliability of .86 (four-
week interval), and adequate validity indicators. The
Spanish version of the REF scale has an α of up to .90
and a retest α of .76 (average interval of 44 days in pa-
tients [53]).
Children’s depression inventory CDI [54]
Spanish version by Del Barrio and Carrasco-Ortiz [55].
This scale comprised of 27 items, which assess depressive
symptomatology in children and adolescents, has a three-
point Likert-type response (0 = “normality”, 1= “Certain
intensity in response” and 2 = “Presence of depressive
symptom). The Spanish adaptation has adequate internal
consistency (Cronbach’s alpha = .79).
Procedure
The SNS scale was translated to Spanish. The translation
was reviewed and approved by the authors of the scale.
Data were acquired from June 2016 to June 2017 at 29
high schools. Authorization to carry out the study was
requested from the schools, and parents were informed
of its purpose and requested their written consent au-
thorizing participation. The evaluation tests were admin-
istered in group by experienced psychologists in the
classrooms at each school.
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Data analysis
A frequency analysis was done of SNS item responses,
and skewness and kurtosis were calculated. Exploratory
Factor Analyses (EFA) were done of the SNS scale on
the polychoric correlations matrix with Robust Diag-
onally Weighted Least Squares (RDWLS) and Direct
Oblimin rotation. A Confirmatory Factor Analysis (CFA)
was done to test the suitability of the internal structure
with the RDWLS method. Chi squared, Comparative Fit
Index (CFI), Goodness of Fit Index (GFI), and the Non-
Normed Fit Index (NNFI) which must be >.90 [56] were
used to test the overall fit of models. In addition to these
indices, the Root Mean Square Error of Approximation
(RMSEA) was calculated at a 90% confidence interval,
which must be ≤ .05 for a good fit, and from .05 to .08
for an acceptable fit. The Standardized Root Mean
Square Residual (SRMR), which must be ≤ .05 for a good
fit, and from .05 to .10 for an acceptable fit [57], was also
calculated. Invariance of measurement of the SNS scale
across sex and age was estimated. The sample was di-
vided into two groups by age, from 11 to 15 years and
from 16 to 18 years. We tested model fit separately for
male and female and for younger and older adolescents
and then a multigroup CFA was done. Configural invari-
ance, in which the latent structure was constrained to be
equal across groups (sex and age), was analyzed, and fac-
tor loadings and thresholds were estimated freely. After
that, scalar invariance, in which the factor loadings and
thresholds were constrained to be equal across sex and
age was analyzed. Model fit was evaluated with the
ΔCFI. There is invariance if the Δ in CFI is <.01 [58].
Reliability was analyzed with the ordinal alpha and
McDonald’s Omega for the total scale. For evidence of
convergent and discriminant validity, bivariate Spearman
Correlation analyses were conducted. Finally, the ROC
curve was calculated for SNS sensitivity and specificity.
Statistical analyses were done with the SPSS, Lisrel 8.7,
and Factor 10.5.03 programs.
Results
Descriptive analysis of the items on the SNS scale
The result of the Mardia’s test of multivariate asym-
metry, skewness and kurtosis was 107.45 (p < .001).
Table 1 shows the means, standard deviations, skew-
ness, kurtosis and percentage of participants who an-
swered the items affirmatively (Options 1 and 2).
The items with the lowest percentage of positive an-
swers were related to the social withdrawal factor
(Items 3 and 4) and anhedonia (Items 17 and 18).
Specifically, 86.7 and 74.6% answered Items 17 and
Table 1 Descriptive statistics of the items on the SNS scale
Items Mean SD skewness kurtosis Percentage of affirmative responsesa
1 .53 .63 .81 −.39 44.9
2 .31 .55 1.62 1.71 26.3
3 .17 .45 2.78 7.07 13.3
4 .31 .58 1.68 1.77 25.4
5 .51 .68 .99 −.25 40
6 .55 .68 .85 −.47 40
7 .56 .75 .92 −.62 40.3
8 .91 .76 .15 −1.27 66
9 .70 .74 .55 −1.01 52.9
10 .35 .63 1.56 1.18 27.1
11 .41 .67 1.36 .50 30.8
12 .59 .74 .83 −.71 43.7
13 .79 .71 .33 −1.01 61.9
14 .72 .70 .72 −.88 57.9
15 1.07 .77 1.07 −1.32 73.3
16 .62 .74 .62 −.84 45.9
17 .25 .53 .25 3.20 20.5
18 .27 .54 .27 2.64 22.2
19 .38 .61 1.37 .78 31.1
20 .61 .74 .77 −.81 45.4
Total 10.57 6.27 .73 .41 –
aPercentage of participants that marked response options 1 and 2
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18 negatively, respectively. Skewness and kurtosis of
items were below 2 and 7 respectively, expect for
Item 3 (skewness = 2.78 and kurtosis = 7.08).
Exploratory factor analysis
The EFA found adequate values in the KMO (.89, 95%
CI = .881, .894) and Bartlett’s Sphericity (χ2 (190) = 14,
040.9, p < .001) tests. Parallel analyses recommended a
one-factor solution, however, the Schwarz’s Bayesian In-
formation Criterion (BIC) and scree plot initially sug-
gested a five-factor solution. These five factors coincide
with the dimensions proposed by the authors of the
scale and explained 57% of the variance. The factor load-
ings are shown in Table 2. The correlations between fac-
tors varied from r = .28 (Anhedonia-Avolition) to r = .55
(Alogia-Social withdrawal).
Confirmatory factor analysis
The CFA was performed with RDWLS estimation on
the asymptotic covariance matrix. Four models were
tested, the five factors found in the EFA (Model 1), the
two factors found with patients by the authors of the
scale (Model 2), a model with the five first-order factors
and one second-order factor (Model 3), which would
allow the SNS scale to be used by adding up its items to
get a total score, and a unidimensional model following
the recommendation of the parallel analyses. Table 3
shows the four models. All the models had adequate fit
indicators. Figure 1 shows the completely standardized
factor loadings for Model 3.
In addition, to check whether the five-factor structure
would be appropriate for participants with psychosis
(schizophrenia), Model 3 was tested with subjects with a
score > = to the 90th percentile on the SNS scale. The
goodness-of-fit indicators were adequate: Satorra Bentler
Chi2 = 267.33 (df = 165), RMSEA .035 [.027, .042], CFI =
.92, NNFI = .90, SRMR = .076.
Invariance of measurement across sex and age
An analysis of invariance of measurement was per-
formed for sex and age. First the goodness-of-fit indica-
tors for males and females were evaluated separately and
then a multigroup CFA was done with the RDWLS
method. The same was done for age. The results showed
configural and scalar invariance of the model across sex
and age (ΔCFI <.01), demonstrating that the factor
structure of the SNS scale, the factor loadings and the
thresholds are equivalent in males and females as well as
ages (see Table 4).
Reliability and evidence of validity of the SNS scale
The internal consistency of the SNS scale and subscales
was estimated by finding the ordinal alpha coefficient on
the polychoric correlations matrix and the McDonald’s
Omega coefficient. The overall alpha for the complete
SNS scale was .92, for social withdrawal it was .75, for
avolition it was .76, for alogia .74, for anhedonia .61 and
for diminished emotional range it was .59. The McDo-
nald’s Omega coefficient was .87. The ASI, REF and CDI
scales had favorable internal consistency (α ASI = .82, α
REF = .82, α CDI = .83).
To study the evidence of convergent and divergent val-
idity, the Spearman’s correlations were found between
the total scores on the CDI depression scale, the REF for
referential thinking, ASI for aberrant salience, and the
SNS total score and factors. As shown in Table 5, all the
correlations were statistically significant. The correlation
results for the total SNS score and the CDI (r = .514)
should be emphasized. The correlation between the ASI
scale and the total SNS score was low, showing evidence
of divergent validity, however, for the REF scale it was
moderate.
The ROC curve was calculated to study the sensitivity
and specificity of the SNS scale. The subjects in one
group, with scores on the REF, ASI and CDI scales over
the 85th percentile, were identified as being at risk (n =
81), and the rest of the sample was in another. The ROC
curve showed a significant area of .81 [95% CI =
Table 2 Exploratory Factor Analysis rotated factor matrix
loadings
DER AN AL AV SW
Item 1 −.069 −.132 .044 .069 .719
Item 2 .029 .024 .042 .029 .721
Item 3 .133 .241 −.014 .011 .489
Item 4 .069 .259 −.034 −.009 .476
Item 5 .452 .035 .195 −.005 −.109
Item 6 .556 .031 −.009 .078 .050
Item 7 .487 .066 −.045 −.041 −.007
Item 8 .327 −.134 .232 .116 .134
Item 9 .218 −.031 .316 .079 .155
Item 10 −.021 −.017 .790 .060 .048
Item 11 .042 −.030 .772 −.072 −.025
Item 12 .006 −.081 .320 .289 .116
Item 13 −.095 −.082 .098 .689 −.013
Item 14 .022 .077 −.027 .656 −.023
Item 15 .080 −.091 .056 .718 .074
Item 16 .095 .058 −.013 .490 .047
Item 17 .096 .339 .220 −.009 .310
Item 18 .074 .517 .105 .223 .047
Item 19 .183 .502 .022 .120 −.005
Item 20 −.029 .296 .112 −.164 .059
Note. DER Diminished Emotional Range; AN Anhedonia, AL Alogia, AV Avolition,
SW Social withdrawal
Primary loadings for each observed variable are in bold
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Table 3 Fit indices of the SNS scale
Model χ2Satorra-Bentler df CFI NNFI SRMR RMSEA [90% CI] AIC
Model 1 1367.44 160 .983 .980 .049 .041 [.039, .043] 1466.79
Model 2 3242.57 169 .958 .953 .070 .063 [.062, .065] 3405.47
Model 3 1413.87 165 .983 .980 .045 .041 [.039, .043] 1503.73
Model 4 3369.12 170 .961 .957 .072 .065 [.063, .066] 3449.12
Note. Model 1: Five factors found from EFA, Model 2: Two factors proposed by the scale’s authors, Model 3: One second-order factor and five first-order factors
found by EFA, Model 4: unidimensional model
Fig. 1 Path diagram and estimates for the five first-order factors related to a second-order of the SNS scale. Note. SW = Social withdrawal; DER =
Diminished Emotional Range; AL Alogia, AV Avolition, AN Anhedonia
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.773–.853] for a cutoff point of 13.5 points, sensitivity of
.73 and specificity of .72. With the sample percentile ap-
plied to the SNS scale (85th percentile, starting from 17
points), 16.96% of the participants were found to have
high NS scores (51.4% males).
Discussion
Early identification of psychosis is a priority which its
development and consequent functional impairment de-
pend on, in addition to personal, family and healthcare
costs [59]. Much of the research has concentrated on
the population that has requested clinical help, and
mainly, with risk criteria based on positive symptomatol-
ogy. However, negative/disorganized symptoms are those
that predict positive symptoms (and not the other way
around), and persistence of the first are a key element in
prediction [29]. Therefore, study of NS such as
Psychotic-Like Experiences (PLEs) during adolescence
could pose an advantage for properly characterizing the
complex process that could culminate in development of
psychosis.
The presence of NS in the general population and in
young people at clinical risk [7, 60] requires simple, brief
measures which facilitate their detection. The main
objective of this study was to adapt and validate the SNS
to Spanish. This would enable its application in a general
adolescent population to identify self-informed NS for
the broad Spanish-speaking context.
Although it is not expected to find a high frequency of
NS in the general adolescent population not requesting
clinical help [26], it is true that their presence may be
demonstrated. This study found that from 13.3 to 73.3%
of adolescents showed some NS on the SNS scale, and
almost 17% had high scores (85th percentile). These re-
sults are near those found by Werbeloff et al. [17].
Therefore, although NS are relatively frequent in the
general population, they are mostly of lower intensity, and
probably transitory [20, 61, 62], which would fit in with
the PLE concept. A cut-off point of 13 was found on the
SNS, with lower sensitivity and specificity indicators than
those reported by the instrument’s authors, probably be-
cause our study focused on the general population. Al-
though this population is known not to usually require
medical attention [25], risk of psychosis is not discarded
[63, 64]. Social withdrawal, and in second place, anhedo-
nia, were the least outstanding NS. This was expected
since lack of interest and disconnection with others are
characteristic indicators of schizophrenia, risk factors with
predictive power for psychosis [34, 65]. The outstanding
factor at any intensity was motivational (avolition), per-
haps reflecting the changes the adolescent has to cope
with until achieving self-regulation: between exploration
and adjustment to external and internal demands [66].
The second objective of this study focused on deter-
mining the factorial structure of the SNS scale. Thus, it
could be shown whether the NS observed in an adoles-
cent general population represent constructs similar to
those found in other studies, usually with patients. The
structure of the SNS scale (EFA) showed the factors pro-
posed by the authors [11] and agreed with NIMH and
MATRICS: alogia, social withdrawal, anhedonia, dimin-
ished emotional range and avolition, even though paral-
lel analysis recommended a unidimensional structure.
Table 4 Multi-group CFAs testing for measurement invariance between sex and age SNS
χ2Satorra-Bentler df CFI NNFI RMSEA [90% CI] SRMR ΔCFI
Sex
Male (n = 2099) 571.13 165 .986 .984 .035 [.032, .038] .048
Female (n = 2422) 976.12 165 .981 .979 .045 [.032, .048] .057
Configural 1393.19 326 .984 .981 .038 [.036, .040] .056
Scalar 1820.44 375 .978 .978 .042 [.039, .043] .068 −.006
Age
Age:11–15 (n = 3301) 1003.96 165 .983 .980 .039 [.036, .042] .049
Age: 16–18 (n = 1220) 541.51 165 .983 .983 .043 [.039, .047] .056
Configural 1372.77 326 .984 .982 .038 [.036, .040] .056
Scalar 2103.62 375 .975 .974 .045 [.043, .047] .073 −.009
Table 5 Spearman’s correlations between total scores on the
REF Referential Thinking Scale, aberrant salience, CDI, SNS and
avolition, social withdrawal, diminished emotional range,
anhedonia and alogia subscales
SNS total AV SW DER AN AL
IR .409** .359** .274** .224** .201** .339**
ASI .311** .311** .237** .162** .104** .235**
CDI .514** .512** .382** .195** .232** .395**
Mean 10.57 3.23 1.32 2.49 1.48 2.04
SD 6.27 2.12 1.52 1.82 1.54 1.82
Note. AV Avolition, SW Social Withdrawal, DER Diminished Emotional Range,
AN Anhedonia, AL Alogia, IR Ideas of reference, ASI Aberrant Salience,
CDI Depression
** p < .01
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The five-factor structure was confirmed (CFA) with ad-
equate indicators and more parsimoniously than the two
avolition/apathy/amotivation and expressive factors ob-
served in patients with schizophrenia [9, 11]. Because of
the recommendation of the parallel analyses to consider
the SNS unidimensional, it was decided to try a second-
order model providing a total score in negative symp-
tomatology which could be used as a criterion of clinical
severity. Considering that a second-order model is more
restrictive than a first-order one and that, in spite of it,
Model 3 has a parsimonious fit, we think it is of interest
to go with this model.
Summarizing, although generally and with an adoles-
cent population, the characteristics observed by the au-
thors of the SNS in an adult population, mainly patients,
were maintained with an internal structure that charac-
terizes general affective-motivational responses, where
the severity with which its absence is observed is rele-
vant in determining the NS, at least as a criterion of
study when applied to a general population like a PLE.
The third objective of this study concentrated on
the way in which adolescents responded to the SNS
scale. The analysis of invariance across sex and age
showed that the SNS can be used without these vari-
ables influencing how the instrument is answered.
This result is relevant considering that adolescents
from 11 years of age participated, and was therefore
shown to be an adaptation of this scale adequate for
its use in this population.
The following objective of the analysis of the psycho-
metric properties of the SNS showed that the reliability
of the overall scale was favorable. Internal consistency
was adequate for social withdrawal, alogia and avolition,
but unfavorable for anhedonia and diminished emotional
range. In the case of anhedonia, Item 20 (interest in
sex), was problematic, above all among the youngest,
and Items 17 and 18 had a very low response. However,
what was on target in this factor was that Item 19 was
related to anticipatory pleasure. The internal consistency
of anhedonia in general could have been problematic,
because its independence from depressive symptomatol-
ogy was not clear with the design applied [67]. It is also
possible that stress attenuates the reward system re-
sponse [68] precisely when studied in youths in the gen-
eral population. Furthermore, the reliability found in the
diminished emotional range factor could be affected by
defining indicators that require either observation by
others (Item 5 considers the point of view of others) or
good capacity for self-evaluation by the adolescent.
In divergent validity, moderate-to-low correlation with
indicators representative of positive symptomatology
(ideas of reference and aberrant salience) shows that
these symptoms are different from NS. A low but not
absent relationship suggests the need to verify, as
pointed out by Jones et al. [63], whether NS and anxiety
can cause errors in processing attributional salience of
anomalies.
The high correlation with depressive symptomatology
does not clarify differentiation between NS and depres-
sive symptoms [69]. The factor most closely related to
depressive symptoms was avolition, and the one which
was the least related was diminished emotional range, as
would be expected from its specificity to the psychotic
scope. The difficulty in differentiating NS from depres-
sive symptoms and whether NS are secondary to depres-
sion, cannot be elucidated with this design [34].
Some suggestions coming out of this study are that
the low indices for prediction of the transition to psych-
osis are due precisely to not taking the mood sympto-
mology into account in its UHR criteria [42, 43]. In like
manner, it is probable that the prodromal indicators
should be considered pleiotropic because they lead to
psychotic and nonpsychotic manifestations (such as de-
pression, anxiety or substance use), so in the evaluation
of PLEs, overlapping can be observed which does not
specify the final trajectory until its persistence and com-
bination with other variables open the way for psychotic
development [70].
The contributions of this study have limitations which
should be taken into account. It is a cross-sectional
study with the drawbacks typical of a single evaluation.
The adolescents considered at risk were part of a clinical
evaluation and follow-up, results of which, for reasons of
space, were not included in this article. This design con-
ditions being able to determine NS as PLE which could
later cause full psychotic development. A prospective de-
sign would be required to find out the true predictive
capacity of the NS as PLE. It should also be kept in mind
that indicators of severity were considered to conceive
psychometric risk, but they were based on a normal
population. This decision is not exempt from drawbacks,
but for the purpose of screening, it may still be useful, as
long as it is corroborated with other measures or ex-
haustive clinical interview.
It is still important to analyze the persistence of NS
and their genetic-environmental context [28, 71] and
premorbid adjustment, to clarify whether NS are
schizotypal/schizoid traits [46, 47] and compare a
group of young people with a first episode of psych-
osis to the results with the general population, limit-
ing their generalization and applicability. Furthermore,
it would have to be demonstrated that the stability of
the measure is reliable. However, replication of the
same NS structure with a general and adolescent
population could be an indirect indicator that this
construct is stable, possibly as a trait. Nevertheless,
the last of the objectives was to verify adequate indi-
cators of sensitivity and specificity for an established
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risk criterion, and this was done. This said, these in-
dicators must be taken with caution in the context of
a first evaluation or screening and not as an estab-
lished risk or with diagnostic characteristics.
Strauss and Gold [72] emphasized that one of the dis-
advantages of self-reports is that they lead to more se-
mantic processing than experiential (e.g., evaluating
beliefs about pleasure). In particular, evaluation of the
emotional range/intensity requires observation more
than subjective appreciation [5], decreased spontaneous
movement being a key indicator of NS severity [73]
which cannot be captured in a self-report. The presence
of false positives is also expectable with self-report mea-
sures, but as suggested by Kaymaz [74], risk is not dis-
carded because of false positives, especially, with high
scores.
Another difficulty was lacking another NS scale to cal-
culate the convergent validity. However, its inclusion
would have lengthened testing, reducing reliability from
tiring during its collective application.
In spite of its limitations, this study offers an outstand-
ing contribution in the scope of evaluation of NS in ado-
lescents, by facilitating the communication of relevant
and complex inner experiences [3], in view of the short-
age of self-report instruments specific to NS.
Conclusion
The SNS scale is measure that could be used for screen-
ing in academic orientation and in healthcare because of
its brief application and simple items. Later evaluation
by the specialist and information from parents and
teachers can culminate in better accuracy in identifica-
tion and follow-up of NS.
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